Top

Published in:

01-12-2020 | Lung Cancer | Commentary

Histopathology of COVID-19 pneumonia in two non-oncological, non-hospitalised cases as a reliable diagnostic benchmark

Authors: Roberto Scendoni, Francesca Marchesani, Nunzia Cannovo, Piergiorgio Fedeli, Mariano Cingolani

Published in: Diagnostic Pathology | Issue 1/2020

Abstract

In lung cancer patients infected with COVID-19, pathological features are not easy to distinguish. This report presents detailed histopathological findings in two non-neoplastic subjects whose out-of-hospital deaths were caused by COVID-19 infection. These ‘pure’ cases differ in the time of presentation of symptoms, the phase of lung anatomopathological patterns (acute lung injury versus diffuse alveolar damage) and the mechanism of death. The results provide a valid diagnostic benchmark for evaluating the evolution of COVID-19 pneumonia.

Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.CrossRef

Tian S, Hu W, Niu L, et al. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020. https://doi.org/10.1016/j.jtho.2020.02.010.

Soubani AO, Shehada E, Chen W, et al. The outcome of cancer patients with acute respiratory distress syndrome. J Crit Care. 2014;29(1):83.e7–183.e12.CrossRef

Azoulay E, Lemiale V, Mokart D, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med. 2014;40(8):1106–14.CrossRef

Young AY, Shannon VR. Acute respiratory distress syndrome in cancer patients. Oncologic Critical Care. 2019:557–82.

Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7.CrossRef

Gralinski LE, Baric RS. Molecular pathology of emerging coronavirus infections. J Pathol. 2015;235(2):185–95.CrossRef

Clerkin KJ, Fried JA, Raikhelkar J, et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. 2020. https://doi.org/10.1161/CIRCULATIONAHA.120.046941.

Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4.CrossRef

10.

Spezzani V, Piunno A, Iselin HU. Benign COVID-19 in an immunocompromised cancer patient – the case of a married couple. Swiss Med Wkly. 2020;150:w20246.PubMed

Title: Histopathology of COVID-19 pneumonia in two non-oncological, non-hospitalised cases as a reliable diagnostic benchmark
Authors: Roberto Scendoni
Francesca Marchesani
Nunzia Cannovo
Piergiorgio Fedeli
Mariano Cingolani
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Lung Cancer
Lung Cancer
Pneumonia
Acute Respiratory Distress-Syndrome
COVID-19
Lung Cancer
Published in: Diagnostic Pathology / Issue 1/2020
Electronic ISSN: 1746-1596
DOI: https://doi.org/10.1186/s13000-020-00990-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Histopathology of COVID-19 pneumonia in two non-oncological, non-hospitalised cases as a reliable diagnostic benchmark

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

A primary neuroendocrine tumor of the left ventricle presenting with diarrhea—an unusual experience and literature review

Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status

Targeted-gene sequencing of an undifferentiated gallbladder carcinoma: a case report

Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases

Detection and stage classification of Plasmodium falciparum from images of Giemsa stained thin blood films using random forest classifiers

Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin’s glands reveals potential new routes for targeted therapies: a case report